ecog 1505 study: no benefit of post-operative avastin in early stage lung cancer patients
Published 8 years ago • 124 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
1:38
ecog1505: will avastin be treatment for early stage lung cancer patients?
-
9:26
adding avastin to tarceva help egfr positive lung cancer patients?
-
14:59
gracecast-074_lung-cancer_ccilc - adjuvant therapy for smaller node-negative nsclc
-
2:12
neoadjuvant, perioperative, adjuvant: defining terms and advantages - onctalk lung 2023
-
4:29
studies in chemoimmunotherapy - lung cancer onctalk 2022
-
12:33
gracecast-025_lung-cancer_questions and trials for nsclc
-
6:29
neoadjuvant chemo /- nivolumab for patients with early stage nsclc - case based panel discussion
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
22:32
gracecast-022_lung-cancer_cancer lifeline lecture part 2 adjuvant chemo
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
5:09
immunotherapy for lung cancer: general concepts
-
4:57
q&a: is biomarker testing common in early stage nsclc? - targeted therapies in lung cancer 2023
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
35:48
gracecast-055_lung-cancer_expert round table - adjuvant therapy for elderly / frail
-
11:12
the future of cancer immunotherapy: combination treatments
-
4:56
immunotherapy for previously treated advanced non-small cell lung cancer
-
3:49
small cell lung cancer clinical trial: is ecog 2511 right for you?
-
1:57
keynote 091: adjuvant pembrolizumab - onctalk lung 2023
-
5:04
pre-operative/neoadjuvant therapy: rationale and indications